POLE and melanoma: For example, melanoma and non-small cell lung carcinomas frequently have high TMB but dMMR, MSI-high or POLE mutations are rare in these tumors [37–39], indicating other mechanisms can contribute to increased TMB [13, 32, 36, 40].